Skip to content

Effect of intratracheal lidocaine on hypoxemia after acute Stanford type-A aortic dissection surgery

Effect of intratracheal lidocaine on hypoxemia after acute Stanford type-A aortic dissection surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059693
Enrollment
Unknown
Registered
2022-05-08
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stanford type A aortic dissection

Interventions

Control Group:Intratracheal injection of normal saline
Experimental group:Intratracheal injection of lidocaine

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the guidelines for the diagnosis and treatment of thoracic aortic disease (TAD) jointly issued by ACC/AHA in 2010, within two weeks after the onset; 2. The patients diagnosed as ATAAD by multi-slice spiral CT and color Doppler ultrasound and planned to undergo emergency surgery, including ascending aortic replacement (AAR), total arch replacement (TAR) and elephant trunk stent; 3. Age: 18-70 years old; 4. Weight: 50kg~100kg; 5. Volunteer to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to lidocaine; 2. Plenty of pericardial effusion and pleural effusion existed before operation; 3. There are factors of airway obstruction before operation, such as continuous bleeding or large amount of sputum; 4. Patients with stroke or spinal cord injury; 5. Previous cardiorespiratory diseases (such as intracardiac shunt, lung cancer, emphysema, pulmonary tuberculosis, COPD, bronchiectasis, etc.), nervous system diseases, hematological system diseases, liver and kidney insufficiency, connective tissue diseases, infection and thrombotic diseases, etc; 6. Severe cardiac insufficiency (LVEF<45%); 7. Pulmonary hypertension; 8. Patients take non-steroidal anti-inflammatory drugs or corticosteroids; 9. Previous cardiac and chest surgery; 10. BMI = 20 kg/m2 or = 30 kg/m2.

Design outcomes

Primary

MeasureTime frame
The incidence of hypoxemia 6 hours after surgery;

Secondary

MeasureTime frame
Intrapulmonary shunt;Four inflammatory response indicators;Three myocardial infarction indicators;Postoperative extubation time;Cardiac surgery intensive care unit stay time;Major adverse cardiovascular events;

Countries

China

Contacts

Public ContactYanwu Jin

The Second Hospital of Shandong University

jinyanwu_aa@163.com+86 15806603618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026